SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

Item
http://www.wikidata.org/entity/Q34855870
Microfluidic platform combining droplets and magnetic tweezers: application to HER2 expression in cancer diagnosis.Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.Concomitant detection of HER2 protein and gene alterations by immunohistochemistry (IHC) and silver enhanced in situ hybridization (SISH) identifies HER2 positive breast cancer with and without gene amplificationHuman epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic CholangiocarcinomaTumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens.HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.HER2 assessment by silver in situ hybridization: where are we now?HER2 testing and its predictive utility in anti-HER2 breast cancer therapy.Advantages and disadvantages of technologies for HER2 testing in breast cancer specimens.Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization for Low and High Throughput HER2 Genetic Testing.Multifractal-based nuclei segmentation in fish images.Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patients.Counting invasive breast cancer cells in the HER2 silver in-situ hybridization test: how many cells are enough?HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study.Application of the 2013 ASCO/CAP guideline and the SISH technique for HER2 testing of breast cancer selects more patients for anti-HER2 treatment.Micromolecular methods for diagnosis and therapeutic strategy: a case study.
P2860

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

Item
http://www.wikidata.org/entity/Q34855870
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@ast
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@en
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@nl
type
label
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@ast
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@en
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@nl
prefLabel
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@ast
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@en
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
SISH/CISH or qPCR as alternati ...... experience based on 840 cases.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P932